Cargando…

Reversible transition from a hypertrophic to a dilated cardiomyopathy

We report the case of a 17‐year‐old female patient with known hypertrophic cardiomyopathy and a Wolff‐Parkinson‐White syndrome. She came to our department for further evaluation of a new diagnosed dilated cardiomyopathy characterized by an enlargement of the left ventricle and a fall in ejection fra...

Descripción completa

Detalles Bibliográficos
Autores principales: Spillmann, Frank, Kühl, Uwe, Van Linthout, Sophie, Dominguez, Fernando, Escher, Felicitas, Schultheiss, Heinz‐Peter, Pieske, Burkert, Tschöpe, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064744/
https://www.ncbi.nlm.nih.gov/pubmed/27774273
http://dx.doi.org/10.1002/ehf2.12072
_version_ 1782460221074964480
author Spillmann, Frank
Kühl, Uwe
Van Linthout, Sophie
Dominguez, Fernando
Escher, Felicitas
Schultheiss, Heinz‐Peter
Pieske, Burkert
Tschöpe, Carsten
author_facet Spillmann, Frank
Kühl, Uwe
Van Linthout, Sophie
Dominguez, Fernando
Escher, Felicitas
Schultheiss, Heinz‐Peter
Pieske, Burkert
Tschöpe, Carsten
author_sort Spillmann, Frank
collection PubMed
description We report the case of a 17‐year‐old female patient with known hypertrophic cardiomyopathy and a Wolff‐Parkinson‐White syndrome. She came to our department for further evaluation of a new diagnosed dilated cardiomyopathy characterized by an enlargement of the left ventricle and a fall in ejection fraction. Clinically, she complained about atypical chest pain, arrhythmic episodes with presyncopal events, and dyspnea (NYHA III) during the last 6 months. Non‐invasive and invasive examinations including magnetic resonance imaging, electrophysiological examinations, and angiography did not lead to a conclusive diagnosis. Therefore, endomyocardial biopsies (EMBs) were taken to investigate whether a specific myocardial disease caused the impairment of the left ventricular function. EMB analysis resulted in the diagnosis of a virus‐negative, active myocarditis. Based on this diagnosis, an immunosuppressive treatment with prednisolone and azathioprine was started, which led to an improvement of cardiac function and symptoms within 3 months after initiating therapy. In conclusion, we show that external stress triggered by myocarditis can induce a reversible transition from a hypertrophic cardiomyopathy to a dilated cardiomyopathy phenotype. This case strongly underlines the need for a thorough and invasive examination of heart failure of unknown causes, including EMB investigations as recommend by the actual ESC position statement.
format Online
Article
Text
id pubmed-5064744
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-50647442016-10-19 Reversible transition from a hypertrophic to a dilated cardiomyopathy Spillmann, Frank Kühl, Uwe Van Linthout, Sophie Dominguez, Fernando Escher, Felicitas Schultheiss, Heinz‐Peter Pieske, Burkert Tschöpe, Carsten ESC Heart Fail Case Report We report the case of a 17‐year‐old female patient with known hypertrophic cardiomyopathy and a Wolff‐Parkinson‐White syndrome. She came to our department for further evaluation of a new diagnosed dilated cardiomyopathy characterized by an enlargement of the left ventricle and a fall in ejection fraction. Clinically, she complained about atypical chest pain, arrhythmic episodes with presyncopal events, and dyspnea (NYHA III) during the last 6 months. Non‐invasive and invasive examinations including magnetic resonance imaging, electrophysiological examinations, and angiography did not lead to a conclusive diagnosis. Therefore, endomyocardial biopsies (EMBs) were taken to investigate whether a specific myocardial disease caused the impairment of the left ventricular function. EMB analysis resulted in the diagnosis of a virus‐negative, active myocarditis. Based on this diagnosis, an immunosuppressive treatment with prednisolone and azathioprine was started, which led to an improvement of cardiac function and symptoms within 3 months after initiating therapy. In conclusion, we show that external stress triggered by myocarditis can induce a reversible transition from a hypertrophic cardiomyopathy to a dilated cardiomyopathy phenotype. This case strongly underlines the need for a thorough and invasive examination of heart failure of unknown causes, including EMB investigations as recommend by the actual ESC position statement. John Wiley and Sons Inc. 2015-12-09 /pmc/articles/PMC5064744/ /pubmed/27774273 http://dx.doi.org/10.1002/ehf2.12072 Text en © 2015 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Spillmann, Frank
Kühl, Uwe
Van Linthout, Sophie
Dominguez, Fernando
Escher, Felicitas
Schultheiss, Heinz‐Peter
Pieske, Burkert
Tschöpe, Carsten
Reversible transition from a hypertrophic to a dilated cardiomyopathy
title Reversible transition from a hypertrophic to a dilated cardiomyopathy
title_full Reversible transition from a hypertrophic to a dilated cardiomyopathy
title_fullStr Reversible transition from a hypertrophic to a dilated cardiomyopathy
title_full_unstemmed Reversible transition from a hypertrophic to a dilated cardiomyopathy
title_short Reversible transition from a hypertrophic to a dilated cardiomyopathy
title_sort reversible transition from a hypertrophic to a dilated cardiomyopathy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064744/
https://www.ncbi.nlm.nih.gov/pubmed/27774273
http://dx.doi.org/10.1002/ehf2.12072
work_keys_str_mv AT spillmannfrank reversibletransitionfromahypertrophictoadilatedcardiomyopathy
AT kuhluwe reversibletransitionfromahypertrophictoadilatedcardiomyopathy
AT vanlinthoutsophie reversibletransitionfromahypertrophictoadilatedcardiomyopathy
AT dominguezfernando reversibletransitionfromahypertrophictoadilatedcardiomyopathy
AT escherfelicitas reversibletransitionfromahypertrophictoadilatedcardiomyopathy
AT schultheissheinzpeter reversibletransitionfromahypertrophictoadilatedcardiomyopathy
AT pieskeburkert reversibletransitionfromahypertrophictoadilatedcardiomyopathy
AT tschopecarsten reversibletransitionfromahypertrophictoadilatedcardiomyopathy